Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Yiling Pharma Invests $20 Million in Israel's HealthWatch

publication date: Jan 17, 2017
Shijiazhuang Yiling Pharma invested $20 million in HealthWatch, an Israeli company that developed a T-shirt-like wearable monitoring device. Sensors are woven into the fabric and communicate with a pickup device for real-time monitoring. $15 million of the total will be invested into HealthWatch, giving Yiling a 23% stake in the company, and $5 million will pay for China rights to the wearable device. Yiling is known primarily as a TCM company. More details....

Stock Symbol: (SHZ: 2603)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here